Cellceutix preclinical data

In a mouse xenograft model of prostate cancer, 200 mg/kg intraperitoneal Kevetrin every other day for 3 weeks significantly reduced tumor volume at 1 week vs. vehicle-treated controls (p<0.01). Specif...